Clindamycin Suppresses Endotoxin Released by Ceftazidime-Treated Escherichia coli O55:B5 and Subsequent Production of Tumor Necrosis Factor Alpha and Interleukin-1β

Treatment of septicemia caused by Escherichia coli with ceftazidime (CAZ) may be associated with the development of septic shock due to the release of bacterial lipopolysaccharide. We examined the suppressive effect of clindamycin (CLDM) on CAZ-induced release of endotoxin by cultured E. coli and th...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kishi, Kenji, Hirai, Kazuhiro, Hiramatsu, Kazufumi, Yamasaki, Tohru, Nasu, Masaru
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 1999
Témata:
Biologic Response Modifiers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC89169/
https://ncbi.nlm.nih.gov/pubmed/10049276
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky